Stereoselective and improved syntheses and anticancer testing of 3′-O-silatranylthymidines

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 24, 2002, Pages 3521-3523

  Black, Christine A ^a   Ucci, Jason W ^a   Vorpagel, Jeremy S ^a   Mauck, Matthew C ^a   Fenlon, Edward E ^a  

^a XAVIER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' O (TRIMETHYLSILATRANYL)THYMIDINE; 3' O SILATRANYLTHYMIDINE; SILANE DERIVATIVE; SILATRANE DERIVATIVE; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FUSED HETEROCYCLIC RINGS; ORGANOSILICON DERIVATIVE; SILATRANE; THYMIDINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DEPROTECTION REACTION; DIASTEREOISOMER; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROLYSIS; STEREOCHEMISTRY; BRAIN TUMOR; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; LUNG TUMOR; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; SYNTHESIS;

ANTINEOPLASTIC AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; ORGANOSILICON COMPOUNDS; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0036889971     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00820-X     Document Type: Article

References (25)

1. Sculimbrene B.R., Decanio R.E., Peterson B.W., Muntel E.E., Fenlon E.E. Tetrahedron Lett. 42:2001;4979.
2. (a) Voronkov M.G. Top. Curr. Chem. 84:1979;77.
3. (b) Grna A., Koo P.H., Hogan J. Anticancer Res. 12:1992;565.
4. (a) Nucleoside Analogues in Cancer Therapy; Cheson, B. D., Keating, M. J., Plunkett, W., Eds. Marcell Dekker, New York, 1997.
5. (b) Nucleotide Analogues as Antiviral Agents; Martin, J. C., Ed. ACS Symposium Series 401. American Chemical Society, Washington DC, 1989.
6. (a) http://dtp.nci.nih.gov
7. (b) Shoemaker, R. H.; Scudiero, D. A.; Melillo, G.; Currens, M. J.; Monks, A.P.; Rabow, A. A.; Covell, D. G.; Sausville, E. A. Curr. Top. Med. Chem. 2002, 2, 229, and references therein.
8. Caldwell, J. Modern Drug Discovery July/August, 1999, 51-60, and references therein.
9. Silicon biochemistry is poorly understood, see: Tacke R. Angew. Chem., Int. Ed. 38:1999;3015.
10. (a) Tokunaga M., Larrow J.F., Kakiuchi F., Jacobsen E.N. Science. 277:1997;936.
11. (b) Jacobsen E.J. Acc. Chem. Res. 33:2000;421.
12. Nugent W.A., Harlow R.L. J. Am. Chem. Soc. 116:1994;6142.
13. 8Si: 458.1959. Found: 458.1958 (0.2 ppm difference).
14. Gelest Inc., Tullytown, PA.
15. (a) Herdle, W. B.; Kanner, B. US Patent 4,255, 348, 1981; Chem. Abstr. 1981, 95, 42336f.
16. (b) Kannengiesser, G.; Damm, F. Bull. Soc. Chim. Fr. 1967, 7, 2492.
17. Nies J.D., Bellama J.M., Ben-zvi N. J. Organomet. Chem. 296:1985;315.
18. (a) Voronkov, M. G. Zelcans, G. Khim. Geterotsikl. Soedin. 1, 43-48; Chem. Abstr 1969, 71, 3363x.
19. (a) Voronkov, M. G. Zelcans, G. Khim. Geterotsikl. Soedin. 1, 43-48; Chem. Abstr 1969, 71, 3363x.
20. (b) Corey, J. Y. Dehydrogenative coupling reactions of hydrosilanes. In Advances in Silicon Chemistry; JAI Press: Greenwich, CT, 1991. Vol. 1, p 327.
21. Asakura J., Robins M.J., Asaka Y., Kim T.H. J. Org. Chem. 61:1996;9026.
22. Sidorkin V.F., Pestunovich V.A., Voronkov M.G. Russ. Chem. Rev. 49:1980;414.
23. Sidorkin V.F., Pestunovich V.A., Voronkov M.G. Russ. Chem. Rev. 49:1980;414.
24. Rybak R.J., Hartline C.B., Qiu Y.-L., Zemlicka J., Harden E., Marshall G., Sommadossi J.-P., Kern E.R. Antimicrob. Agents Chemother. 44:2000;1506.
25. Korba, B. E. Antiviral Res. 1996, 29, 49, and references therein.